UBS AM
MLAB icon

UBS AM’s Mesa Laboratories MLAB Stock Holding History

UBS AM’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,403
Closed -$1.64M – 2471
2025
Q2 		$1.64M Sell
17,403
-2,574
-13% -$282K ﹤0.01% 2230
2025
Q1 		$2.37M Buy
19,977
+685
+4% +$93.4K ﹤0.01% 1909
2024
Q4 		$2.54M Buy
19,292
+9,189
+91% +$1.13M ﹤0.01% 1927
2024
Q3 		$1.31M Buy
10,103
+1,708
+20% +$201K ﹤0.01% 2255
2024
Q2 		$728K Buy
8,395
+6,080
+263% +$637K ﹤0.01% 2515
2024
Q1 		$254K Hold
2,315
– – ﹤0.01% 2430
2023
Q4 		$243K Hold
2,315
– – ﹤0.01% 2464
2023
Q3 		$243K Sell
2,315
-1,526
-40% -$195K ﹤0.01% 2474
2023
Q2 		$671K Hold
3,841
– – ﹤0.01% 2196
2023
Q1 		$671K Hold
3,841
– – ﹤0.01% 2196
2022
Q4 		$638K Buy
3,841
+632
+20% +$99K ﹤0.01% 2074
2022
Q3 		$452K Hold
3,209
– – ﹤0.01% 2378
2022
Q2 		$654K Hold
3,209
– – ﹤0.01% 2177
2022
Q1 		$818K Hold
3,209
– – ﹤0.01% 2246
2021
Q4 		$1.05M Hold
3,209
– – ﹤0.01% 2191
2021
Q3 		$970K Hold
3,209
– – ﹤0.01% 2182
2021
Q2 		$870K Sell
3,209
-1,663
-34% -$422K ﹤0.01% 2280
2021
Q1 		$1.19M Hold
4,872
– – ﹤0.01% 2005
2020
Q4 		$1.4M Hold
4,872
– – ﹤0.01% 1828
2020
Q3 		$1.24M Buy
4,872
+205
+4% +$48.7K ﹤0.01% 1756
2020
Q2 		$1.01M Buy
4,667
+1,482
+47% +$342K ﹤0.01% 1800
2020
Q1 		$720K Buy
3,185
+17
+0.5% +$4.19K ﹤0.01% 1823
2019
Q4 		$790K Buy
3,168
+849
+37% +$199K ﹤0.01% 2038
2019
Q3 		$551K Buy
2,319
+1,226
+112% +$283K ﹤0.01% 2245
2019
Q2 		$267K Buy
+1,093
New +$255K ﹤0.01% 2449

Other funds holding MLAB

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

UBS AM's MLAB Position: Q3 2025 in Review

UBS AM sold out of Mesa Laboratories (MLAB) in Q3 2025, closing a stake of 17,403 shares — an estimated $1.64M sold.

UBS AM first reported a position in MLAB in Q2 2019 and held it in 25 quarters. The position peaked at $2.54M in Q4 2024. 141 funds tracked by Wall St. Rank hold MLAB as of Q3 2025.

  • UBS AM reported no remaining Mesa Laboratories position as of Q3 2025 after selling out during the quarter.
  • UBS AM sold 17,403 Mesa Laboratories shares in Q3 2025, an estimated $1.64M.
  • UBS AM first reported a position in Mesa Laboratories in Q2 2019 and held it in 25 quarters.
  • UBS AM's Mesa Laboratories position peaked at $2.54M in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2025.

Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.